HealthcareServices

Therapeutic Plasma Exchange Market Outlook: Growth and Forecast Highlights 2030

March 3, 2026March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the therapeutic plasma exchange market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Therapeutic Plasma Exchange Market show for the 2026–2030 period?

The therapeutic plasma exchange market size has experienced strong growth in recent years. It is anticipated to increase from $1.61 billion in 2025 to $1.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.4%. The expansion observed in the historic period is attributable to an increase in the diagnosis of autoimmune disorders, the broadening of hospital transfusion services, the accessibility of centrifugation-based technologies, rising clinician familiarity with apheresis procedures, and the adoption of standardized treatment protocols.

The therapeutic plasma exchange market is projected to experience substantial expansion over the next few years. It is anticipated to grow to $2.4 billion in 2030, driven by a compound annual growth rate (CAGR) of 8.0%. This growth during the forecast period can be attributed to an escalating demand for advanced autoimmune therapies, the increasing adoption of membrane separation technology, the expansion of outpatient apheresis services, rising investment in blood purification technologies, and an elevated focus on personalized immunological treatments. Key trends identified for this period encompass the growing integration of automated plasma exchange systems, the expanding application of tpe in neurological disorders, a heightened demand for high-efficiency separation technologies, the proliferation of hospital-based apheresis units, and an intensified emphasis on treatment safety and continuous monitoring.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15683&type=smp

What Drivers Are Shaping The Development Of The Therapeutic Plasma Exchange Market?

The increasing occurrence of hematological disorders is anticipated to fuel the expansion of the therapeutic plasma exchange market going forward. These conditions, also known as blood disorders, refer to medical issues impacting the blood and blood-forming tissues, including the bone marrow, lymph nodes, and spleen. The rise in hematological disorders is attributed to factors like genetic predispositions, environmental influences, and lifestyle changes. Therapeutic plasma exchange (TPE) is employed in these disorders to extract pathogenic substances from the plasma, such as autoantibodies in autoimmune hemolytic anemia or immune complexes in thrombotic thrombocytopenic purpura, thereby lessening disease severity and improving patient outcomes. For instance, in July 2024, Cancer Research UK, a UK-based charity, reported that the average number of new Hodgkin lymphoma cases per year in the UK is projected to rise from approximately 2,400 cases in 2023-2025 to around 2,900 cases in 2038-2040. Consequently, the high prevalence of hematological disorders is driving the growth of the therapeutic plasma exchange market.

What Segment Types Are Examined In The Therapeutic Plasma Exchange Market?

The therapeutic plasma exchange market covered in this report is segmented –

1) By Type: Therapeutic Plasma Exchange (TPE), Double Filtered Plasmapheresis (DFPP)

2) By Indication: Neurological Disorders, Hematological Disorders, Renal Disorders, Metabolic Disorders, Other Indications

3) By Technology: Centrifugation, Membrane Separation

4) By End User: Blood Collection Centers, Hospitals And Clinics, Transfusion Centers, Other End Users

Subsegments:

1) By Therapeutic Plasma Exchange (TPE): Manual TPE, Automated TPE

2) By Double Filtered Plasmapheresis (DFPP): Single-Stage DFPP, Multi-Stage DFPP

What Trends Are Reshaping The Dynamics Of The Therapeutic Plasma Exchange Market?

Key players within the therapeutic plasma exchange market are prioritizing improvements in automation, device safety, and system efficiency to enhance clinical adoption and streamline operational processes. Automation refers to the use of systems and technology to perform tasks autonomously, without the need for constant human oversight. For example, in November 2024, Terumo BCT, a US-based medical device company, launched software update V12.1 for its flagship Spectra Optia Apheresis System. This update improves usability, strengthens cybersecurity, and optimizes workflow, which includes an automatic pump pause during single needle exchange and reduced alarm occurrences. The system effectively supports therapeutic plasma exchange, demonstrating a mean plasma removal efficiency of 87 %, a minimal extracorporeal volume of 141 mL, and only 1.0 % median platelet loss. While this progression towards sophisticated automation and enhanced device safety is driving increased TPE uptake in hospitals and specialty clinics, the high initial investment cost and the requirement for trained personnel still constrain its adoption in settings with limited resources.

Who Are The Major Companies Operating In The Therapeutic Plasma Exchange Market?

Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Octapharma AG, Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Therapeutic Plasma Exchange Market?

North America was the largest region in the therapeutic plasma exchange market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Therapeutic Plasma Exchange Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15683&type=smp

Browse Through More Reports Similar to the Global Therapeutic Plasma Exchange Market 2026, By The Business Research Company

Blood Plasma Derivatives Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Convalescent Plasma Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Plasma Protein Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795